Event Date/Time: Jun 14, 2012
End Date/Time: Jun 15, 2012
CEE, CIS together with SEE and Turkey represent attractive arenas for pharma companies due to the wide availability of untreated patients, insufficient access to preventive medicine as well as lower costs. Recent tendencies of rising healthcare costs, increasing power of payers together with cost-containment measures implemented by governments generate the need to address this new market reality.
These and many other challenges that all industry stakeholders are facing in the region, will be discussed at the Pharma Excellence in the CEE, CIS, SEE & Turkey event.